nitroaspirin has been researched along with Arteriosclerosis, Coronary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butt, M; Lip, GY; Shantsila, E; Siddique, A | 1 |
| Beghi, C; Bonadonna, S; Corradi, D; De Cicco, G; Gherli, T; Giustina, A; Lorusso, R; Maestri, R; Mancini, T; Poli, E | 1 |
1 review(s) available for nitroaspirin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
New antiplatelet drugs: beyond aspirin and clopidogrel.
Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Drug Design; Humans; Imines; Lactones; Naphthalenes; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propionates; Purinergic P2 Receptor Antagonists; Pyridines; Thiophenes; Ticagrelor; Ticlopidine | 2009 |
1 trial(s) available for nitroaspirin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG.
Topics: Acetylcholine; Aged; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fibrinolytic Agents; Humans; Male; Nitroprusside; Saphenous Vein; Transplants; Vasoconstriction; Vasodilator Agents | 2007 |